Search

everythinglearnresearchcommunity

for

Search:↓

KAP-depleted hair causes less immune response and is more biocompatible for implants.

Psoriasis is the most common cause of erythroderma, and proper medical follow-up is crucial.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Minoxidil, a hair loss treatment, works better and has fewer side effects when put into tiny particles called transethosomes, especially those containing oleic acid.

Curcumin can be effectively loaded into polystyrene nanoparticles, which are safe for human cells and more biocompatible with curcumin inside.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Latanoprost-loaded nanotransfersomes could help treat hair loss by promoting hair growth.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Using old drugs for new uses can help treat rare immune deficiencies.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Getting ethical approval for research with children is important but can be complex and time-consuming, sometimes leading to the exclusion of certain age groups.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

Oral minoxidil helps with hair growth but needs more research to fully understand its effectiveness and safety.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Laser hair transplantation can be effective but should be limited to small areas and requires more training to ensure safety and effectiveness.

LLLT devices for hair loss need more research to define proper guidelines.

Nanotechnology shows promise for better chronic wound healing but needs more research.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Microneedles help improve drug delivery through the skin and are used in medicine and beauty treatments.

Ethosomes could improve how well skin treatments work, but more research is needed on their safety and stability.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.